GalNAc-T16, soluble fragment, Human Recombinant

GalNAc-T16, soluble fragment, Human Recombinant is available at Gentaur for Next week delivery.

Involved in the pathway protein glycosylation

Biomolecule/Target: GALNT16

Alternates names: Polypeptide N-acetylgalactosaminyltransferase, Protein-UDP acetylgalactosaminyltransferase, GALNTL1, GALNT16

Synonyms: Polypeptide N-acetylgalactosaminyltransferase, Protein-UDP acetylgalactosaminyltransferase, GALNTL1, GALNT16

Background Information: Polypeptide N-acetylgalactosaminyltransferase 16 (GalNAc-T16) catalyzes the transfer of N-acetylgalactosamine (GalNAc) from UDP-GalNAc to the hydroxyl group of serine and threonine residues. Twenty GalNAc-T genes have been identified in humans and most have been shown to represent active GalNAc-Ts. All isoforms are type II transmembrane proteins, with different but partly overlapping substrate preferences. The GalNAc-Ts control the initiation of mucin-type O-linked glycosylation and determine the location and density of O-glycans in a protein. Addition of GalNAc to an unglycosylated Ser/Thr residue creates the Tn antigen GalNAcα1-S/T, and subsequent addition of sialic acid by ST6GalNAc-I forms the cancer associated STn antigen.

Reconstitution Instructions: N/A

NCBI Gene Symbol: GALNT16

Gene ID: 57452

NCBI Accession: Q68VJ8